Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caryn Lerman

Showing results (171-180 of 283) with videos related to

Pageof 29
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Cancer epidemiology, biomarkers & prevention, and cancer prevention research: two journals, a common goalTimothy R Rebbeck, Powel H Brown, Ernest T Hawk, et al.
Nature Reviews. Drug Discovery|August 11, 2007
Translational research in medication development for nicotine dependenceCaryn Lerman, Mark G LeSage, Kenneth A Perkins, et al.
Journal of Healthcare Leadership|June 7, 2018
What a medical school chair wants from the deanRobert Hromas, Robert Leverence, Lazarus K Mramba, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patientsMarc D Schwartz, Caryn Lerman, Barbara Brogan, et al.
Pharmacogenetics and Genomics|June 16, 2009
A systems biology network model for genetic association studies of nicotine addiction and treatmentPaul D Thomas, Huaiyu Mi, Gary E Swan, et al.
Addiction Biology|March 19, 2013
Age-related differences in working memory deficits during nicotine withdrawalMary Falcone, E Paul Wileyto, Kosha Ruparel, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 23, 2005
Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropionE Paul Wileyto, Freda Patterson, Raymond Niaura, et al.
Addiction Biology|April 22, 2011
Brain activity and emotional processing in smokers treated with vareniclineJames Loughead, Riju Ray, E Paul Wileyto, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 2, 2013
The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sexAndy Z X Zhu, Caroline C Renner, Dorothy K Hatsukami, et al.
Obesity (Silver Spring, Md.)|December 1, 2006
No evidence for a major role of polymorphisms during bupropion treatmentJianfang Hu, David T Redden, Wade H Berrettini, et al.
Pageof 29

Showing results (171-180 of 283) with videos related to

Sort By:
Pageof 29
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Cancer epidemiology, biomarkers & prevention, and cancer prevention research: two journals, a common goalTimothy R Rebbeck, Powel H Brown, Ernest T Hawk, et al.
Nature Reviews. Drug Discovery|August 11, 2007
Translational research in medication development for nicotine dependenceCaryn Lerman, Mark G LeSage, Kenneth A Perkins, et al.
Journal of Healthcare Leadership|June 7, 2018
What a medical school chair wants from the deanRobert Hromas, Robert Leverence, Lazarus K Mramba, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patientsMarc D Schwartz, Caryn Lerman, Barbara Brogan, et al.
Pharmacogenetics and Genomics|June 16, 2009
A systems biology network model for genetic association studies of nicotine addiction and treatmentPaul D Thomas, Huaiyu Mi, Gary E Swan, et al.
Addiction Biology|March 19, 2013
Age-related differences in working memory deficits during nicotine withdrawalMary Falcone, E Paul Wileyto, Kosha Ruparel, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 23, 2005
Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropionE Paul Wileyto, Freda Patterson, Raymond Niaura, et al.
Addiction Biology|April 22, 2011
Brain activity and emotional processing in smokers treated with vareniclineJames Loughead, Riju Ray, E Paul Wileyto, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 2, 2013
The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sexAndy Z X Zhu, Caroline C Renner, Dorothy K Hatsukami, et al.
Obesity (Silver Spring, Md.)|December 1, 2006
No evidence for a major role of polymorphisms during bupropion treatmentJianfang Hu, David T Redden, Wade H Berrettini, et al.
Pageof 29